Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Mitral Valve Disease Market to reach USD 5.34 billion by the end of 2030.

Global Mitral Valve Disease Market Size Study & Forecast, by Type (Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy, Mitral Valve Therapeutics), by Indication (Mitral Valve Stenosis, Mitral Valve Prolapse, Mitral Valve Regurgitation), by End User (Hospitals, Ambulatory Surgical Centers, Others) and Regional Analysis, 2023-2030

Product Code: HLSMDE-91537830
Publish Date: 4-08-2023
Page: 200

Global Mitral Valve Disease Market is valued at approximately USD 2.72 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.8% over the forecast period 2023-2030. Mitral valve disease refers to a medical condition that affects the mitral valve, which is one of the heart’s four valves responsible for regulating blood flow between the left atrium and left ventricle. The disease encompasses various abnormalities of the mitral valve, including mitral regurgitation, mitral stenosis, and mitral valve prolapse. The market for mitral valve treatment is experiencing growth due to factors such as the rising awareness among individuals about mitral valve disease, the increasing prevalence of risk factors such as high blood pressure, high cholesterol, and changes in lifestyle habits. These factors collectively contribute to the growing demand for mitral valve treatment products and drive the overall market growth across the globe

The increasing prevalence of Mitral regurgitation (MR) is primarily driving the expansion of the mitral valve disease market. As per the National Institutes of Health report released in 2021, mitral regurgitation (MR) holds the distinction of being the most prevalent valvular abnormality on a global scale. It impacts more than 2% of the entire population and exhibits a prevalence that rises with advancing age. The market growth is further propelled by the increasing demand for minimally invasive procedures to treat mitral valve diseases, as well as the subsequent advancements and development of minimally invasive products in this field. However, the growth of the market for mitral valve disease is hindered by the substantial costs associated with the repair and replacement surgeries procedures of the mitral valve, as well as the stringent regulations imposed by governing bodies for the development, usage, and approval of mitral heart valves and medications throughout the forecast period of 2023-2030.

The key regions considered for the Global Mitral Valve Disease Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of well-developed healthcare infrastructure, higher consumer awareness regarding mitral valve diseases, the presence of major players in the United States, and a wide range of offerings in the mitral valve treatment sector. Asia Pacific is expected to fastest growing region during the forecast period, owing to factors such as the large population base and the rising healthcare expenditure in countries such as China and India.

Major market players included in this report are:
Teva Pharmaceutical Industries Ltd.
Corcym UK Limited
Abbott Laboratories
Zydus Lifesciences Limited
Medtronic plc
Edwards Lifesciences Corporation
Affluent Medical
ShockWave Medical, Inc.
Valcare Medical
Pfizer Inc.

Recent Developments in the Market:
Ø In November 2021, Medtronic plc. released preliminary data on the Intrepid transcatheter mitral valve replacement (TMVR) system, which was used in patients with severe and symptomatic mitral valve regurgitation (MR) through the transfemoral access route. The data from the initial five patients enrolled in an Early Feasibility Study of the Intrepid Transfemoral System demonstrated a 100% survival rate with no reported strokes.
Ø In June 2021, Gyrus Capital acquired LivaNova Plc.’s heart valve company and formed a new global medical device company named it as Corcym. This independent company aims to focus on delivering optimal solutions to combat structural heart disease for patients and heart surgeons.

Global Mitral Valve Disease Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Type, Indication, End User, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Mitral Valve Repair
Mitral Valve Replacement
Cardiac Resynchronization Therapy
Mitral Valve Therapeutics

By Indication:
Mitral Valve Stenosis
Mitral Valve Prolapse
Mitral Valve Regurgitation

By End User:
Hospitals
Ambulatory Surgical Centers
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Mitral Valve Disease Market, by Region, 2020-2030 (USD Billion)
1.2.2. Mitral Valve Disease Market, by Type, 2020-2030 (USD Billion)
1.2.3. Mitral Valve Disease Market, by Indication, 2020-2030 (USD Billion)
1.2.4. Mitral Valve Disease Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Mitral Valve Disease Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Mitral Valve Disease Market Dynamics
3.1. Mitral Valve Disease Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising awareness among individuals about mitral valve disease
3.1.1.2. Increasing prevalence of risk factors such as high blood pressure, high cholesterol, and changes in lifestyle habits
3.1.2. Market Challenges
3.1.2.1. High cost of mitral valve replacement and repair procedures
3.1.2.2. Stringent regulations imposed by governing bodies
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation of minimally invasive products
3.1.3.2. Increasing demand for minimally invasive procedures to treat mitral valve diseases
Chapter 4. Global Mitral Valve Disease Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Mitral Valve Disease Market, by Type
5.1. Market Snapshot
5.2. Global Mitral Valve Disease Market by Type, Performance – Potential Analysis
5.3. Global Mitral Valve Disease Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. Mitral Valve Disease Market, Sub Segment Analysis
5.4.1. Mitral Valve Repair
5.4.2. Mitral Valve Replacement
5.4.3. Cardiac Resynchronization Therapy
5.4.4. Mitral Valve Therapeutics
Chapter 6. Global Mitral Valve Disease Market, by Indication
6.1. Market Snapshot
6.2. Global Mitral Valve Disease Market by Indication, Performance – Potential Analysis
6.3. Global Mitral Valve Disease Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
6.4. Mitral Valve Disease Market, Sub Segment Analysis
6.4.1. Mitral Valve Stenosis
6.4.2. Mitral Valve Prolapse
6.4.3. Mitral Valve Regurgitation
Chapter 7. Global Mitral Valve Disease Market, by End User
7.1. Market Snapshot
7.2. Global Mitral Valve Disease Market by End User, Performance – Potential Analysis
7.3. Global Mitral Valve Disease Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
7.4. Mitral Valve Disease Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Ambulatory Surgical Centers
7.4.3. Others
Chapter 8. Global Mitral Valve Disease Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Mitral Valve Disease Market, Regional Market Snapshot
8.4. North America Mitral Valve Disease Market
8.4.1. U.S. Mitral Valve Disease Market
8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Indication breakdown estimates & forecasts, 2020-2030
8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Mitral Valve Disease Market
8.5. Europe Mitral Valve Disease Market Snapshot
8.5.1. U.K. Mitral Valve Disease Market
8.5.2. Germany Mitral Valve Disease Market
8.5.3. France Mitral Valve Disease Market
8.5.4. Spain Mitral Valve Disease Market
8.5.5. Italy Mitral Valve Disease Market
8.5.6. Rest of Europe Mitral Valve Disease Market
8.6. Asia-Pacific Mitral Valve Disease Market Snapshot
8.6.1. China Mitral Valve Disease Market
8.6.2. India Mitral Valve Disease Market
8.6.3. Japan Mitral Valve Disease Market
8.6.4. Australia Mitral Valve Disease Market
8.6.5. South Korea Mitral Valve Disease Market
8.6.6. Rest of Asia Pacific Mitral Valve Disease Market
8.7. Latin America Mitral Valve Disease Market Snapshot
8.7.1. Brazil Mitral Valve Disease Market
8.7.2. Mexico Mitral Valve Disease Market
8.8. Middle East & Africa Mitral Valve Disease Market
8.8.1. Saudi Arabia Mitral Valve Disease Market
8.8.2. South Africa Mitral Valve Disease Market
8.8.3. Rest of Middle East & Africa Mitral Valve Disease Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Teva Pharmaceutical Industries Ltd.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Corcym UK Limited
9.3.3. Abbott Laboratories
9.3.4. Zydus Lifesciences Limited
9.3.5. Medtronic plc
9.3.6. Edwards Lifesciences Corporation
9.3.7. Affluent Medical
9.3.8. ShockWave Medical, Inc.
9.3.9. Valcare Medical
9.3.10. Pfizer Inc
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now